LCL-WEI

Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it

P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

This is the complete description of the cell line that you selected. By clicking on a generic term (e.g., SPECIES) you will go to the corresponding index (e.g., index of species), while by clicking on a specific term (e.g., retinoblastoma) you will go to the list of corresponding cell lines (e.g., retionoblastoma cell lines).

LCL-WEI (human, lymphoblastoid B cell, melanoma)

SPECIES: human
TISSUE/ORGAN: lymphoblastoid B cell
TUMOR: melanoma

DSMZ catalog code: ACC 218
Morphology: lymphoblastoid cells growing singly and in large clumps in suspension
Description: human B-lymphoblastoid cells (from patient with melanoma) Epstein-Barr virus-positive cell line established from peripheral blood in 1977 from patient with melanoma confirmed as human with IEF of MDH, NP
Viruses: ELISA: reverse transcriptase negative; PCR: EBV+, HBV-, HCV-, HHV-8-, HIV-, HTLV-I/II-
Depositor: Dr. H. W. L. Ziegler-Heitbrock, Institute of Immunology, Munich, Germany
General Restrictions

Available in the following LABORATORY:

German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig)
80-90% RPMI 1640 + 10-20% FBS maintain at about 0.3-1.0 x 106 cells/ml; optimal split ratio of 1:3 to 1:8 every 2-4 days at 37C with 5% CO2 saturation density at about 2.0 x 106 cells/ml; doubling time of about 30-40 hours; frozen with 70% medium, 20% FBS, 10% DMSO at about 6 x 106 cells/ampoule; contamination was eliminated with Baytril (enrofloxacin), then negative in DAPI, microbiological culture, RNA hybridization assays;
Validated by: cytogenetics 1 (human near-tetraploid karyotype with diploid (36%) sideline and 4% polyploidy; 90(88-94)<4n>XX/XXY/XXYY; no consistent structural aberrations) * DNA fingerprinting (unique HinfI (gtg)5 DNA profile) * immunological analysis (CD3- CD10- CD13- CD19+ (50%) CD20+ (98%) CD37+ (80%) HLA-DR+ (98%) smIgG- (?) smIgM- smIgkappa- smIglambda cyIgG+ cyIgM- cyIgkappa+ cyIglamda-) * isoenzymes (confirmed as human with IEF of MDH, NP) * reverse transcriptase (reverse transcriptase not detected)

For information, get in touch with:
IRCCS Ospedale Policlinico San Martino
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it

If you want to cite CLDB and HyperCLDB, please use the following reference:

P. Romano, A. Manniello, O. Aresu, M. Armento, M. Cesaro, B. Parodi.
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.
Nucleic Acids Research 2009 37(Database issue):D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105